* Lifestance Health Group Inc reported a quarterly adjusted loss of 2 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -17 cents. The mean expectation of eight analysts for the quarter was for a loss of 7 cents per share. Wall Street expected results to range from -8 cents to -5 cents per share.
* Revenue rose 19% to $312.72 million from a year ago; analysts expected $302.60 million.
* Lifestance Health Group Inc's reported EPS for the quarter was a loss of 2 cents.
* The company reported a quarterly loss of $5.96 million.
* Lifestance Health Group Inc shares had risen by 1.9% this quarter and lost 8.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 5.8% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the healthcare facilities & services peer group is "hold."
Wall Street's median 12-month price target for Lifestance Health Group Inc is 7.75 This summary was machine generated from LSEG data November 7 at 02:45 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.07 -0.02 Beat
Jun. 30 2024 -0.09 -0.06 Beat
Mar. 31 2024 -0.09 -0.06 Beat
Dec. 31 2023 -0.09 -0.12 Missed
Comments